As on March 16, 2023, Jaguar Health Inc. (NASDAQ: JAGX) started slowly as it slid -9.00% to $0.91. During the day, the stock rose to $1.01 and sunk to $0.8817 before settling in for the price of $1.00 at the close. Taking a more long-term approach, JAGX posted a 52-week range of $0.95-$61.12.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 98.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 60.80%. This publicly-traded company’s shares outstanding now amounts to $1.94 million, simultaneously with a float of $1.62 million. The organization now has a market capitalization sitting at $1.97 million. At the time of writing, stock’s 50-day Moving Average stood at $3.9866, while the 200-day Moving Average is $12.8751.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 52 employees. For the Profitability, stocks gross margin was +46.18, operating margin was -939.05 and Pretax Margin of -1213.38.
Jaguar Health Inc. (JAGX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Jaguar Health Inc.’s current insider ownership accounts for 14.92%, in contrast to 3.90% institutional ownership. According to the most recent insider trade that took place on Dec 31, this organization’s Chief of Staff, CCO & GC bought 317 shares at the rate of 0.03, making the entire transaction reach 10 in total value, affecting insider ownership by 6,983.
Jaguar Health Inc. (JAGX) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2022, the company posted -$9 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$5.62) by -$3.38. This company achieved a net margin of -1213.26 while generating a return on equity of -365.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Jaguar Health Inc.’s EPS increase for this current 12-month fiscal period is 60.80% and is forecasted to reach -37.50 in the upcoming year.
Jaguar Health Inc. (NASDAQ: JAGX) Trading Performance Indicators
Let’s observe the current performance indicators for Jaguar Health Inc. (JAGX). It’s Quick Ratio in the last reported quarter now stands at 0.70. The Stock has managed to achieve an average true range (ATR) of 0.26. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.18.
In the same vein, JAGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -58.95, a figure that is expected to reach -9.75 in the next quarter, and analysts are predicting that it will be -37.50 at the market close of one year from today.
Technical Analysis of Jaguar Health Inc. (JAGX)
Through scrutinizing the latest numbers posted by the [Jaguar Health Inc., JAGX], it can be observed that its last 5-days Average volume of 3.53 million was better the volume of 0.93 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 3.96% While, its Average True Range was 0.2096.
Raw Stochastic average of Jaguar Health Inc. (JAGX) in the period of the previous 100 days is set at 0.25%, which indicates a major fall in contrast to 2.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 28.77% that was lower than 85.79% volatility it exhibited in the past 100-days period.